QR-Code

Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.

Owing to the broad spectrum of activity afforded by beta-lactam-beta-lactamase inhibitor preparations, these agents are frequently selected as empiric therapy for the treatment of mixed infections such as intra-abdominal and diabetic foot infections, either alone or in combination with an aminoglyco...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Veröffentlicht in:Antimicrob Agents Chemother
Hauptverfasser: Klepser, M E, Marangos, M N, Zhu, Z, Nicolau, D P, Quintiliani, R, Nightingale, C H
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology (ASM) 1997
Schlagworte:
Online-Zugang:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163725/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9021203/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.2.435
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!